Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0791
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.416
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.596
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0198
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Creatinine
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Cldn13em1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0338
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.138
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.364
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Triglycerides
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0214
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:45m
|
|
|
NotProcessed |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0853
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.177
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.787
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.157
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
3f:2m
|
|
|
NotProcessed |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.149
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.885
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.203
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.524
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0111
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.267
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.530
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.784
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.109
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.406
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.462
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.905
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.771
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.930
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.895
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.694
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.783
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Creatinine
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.499
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0461
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
9.56×10-05
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
1.60×10-06
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.264
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.793
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.944
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0208
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.761
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
3f:2m
|
|
|
NotProcessed |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.655
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.963
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0268
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.958
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0229
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.643
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
3f:2m
|
|
|
NotProcessed |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
2.95×10-05
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.180
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0153
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.375
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
7.21×10-05
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
3f:2m
|
|
|
NotProcessed |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.09×10-05
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.460
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.740
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0822
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.971
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.277
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.431
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
3f:2m
|
|
|
NotProcessed |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0122
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.371
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000792
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.748
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:35m
|
|
|
NotProcessed |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:35m
|
|
|
NotProcessed |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0459
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0319
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.133
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
6f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.260
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0525
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.147
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Plasma Chemistry / Glucose
|
HOM
|
8f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.314
|
Successful |
Cldn13tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
7.30×10-05
|
Successful |
Cldn13em1(IMPC)J
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.529
|
Successful |